CHOU2 PHARMA Partners with Ethos Discovery to Study Potential New Therapy for Canine Idiopathic Epilepsy
Chou2 Pharma LLC, a company focused on advancing the therapeutic use of cannabinoid molecules in veterinary medicine, is pleased to announce that the company has initiated a new study in partnership with Ethos Discovery to evaluate pharmacokinetics of a potential new proprietary animal drug formulation for treating idiopathic epilepsy in dogs. The study is scheduled […]